C. Lawrence

416 citations

18 papers · 311 indexed · h-index 10

Impact in

Hematology top 10%
- Blood groups and transfusion
- Iron Metabolism and Disorders
Genetics
- Hemoglobinopathies and Related Disorders

Papers in

Hematology 7
- Blood groups and transfusion 4
Genetics 6
- Hemoglobinopathies and Related Disorders 5

Co-authors: Marguerite M.B. Kay RL Nagel ME Fabry Lesley J. Bruce M J A Tanner José R. Romero M E Fabry Peter C. Enzinger
Journals: Journal of Clinical Oncology (2 papers)Blood (2 papers)The Journal of Membrane Biology (1 paper)Bone Marrow Transplantation (1 paper)Cephalalgia (1 paper)
Partner nations: United States France United Kingdom

In The Last Decade

C. Lawrence

18 papers receiving 304 citations

Peers

Replace Guy H. Grayson with:

Guy H. Grayson United States

ST Sawyer United States

Alexis Caulier France

R Kastally France

J. D. Hoyer United States

Dharmvir S. Verma United States

Paul Mead United Kingdom

Masae Matsumoto Japan

Albert I. Pick Israel

L Bonazzi Italy

C. Lawrence relative to Guy H. Grayson United States Guy H. Grayson's profile →

Citations per field

00.5×2×4×6×

Guy H. Grayson · 1×

×0.7 85/115

HEMAT

×1.0 77/78

GENET

×0.7 127/193

PHYSI

×2.9 87/30

ONCOL

×1.4 53/38

PPCH

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by C. Lawrence

Since Specialization

Citations

This map shows the geographic impact of C. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lawrence more than expected).

Fields of papers citing papers by C. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lawrence. The network helps show where C. Lawrence may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Lawrence Line = papers co-authored together C. Lawrence links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Successful pediatric ECMO in a rare case of septic shock due to a community-acquired Legionella infection Médecine et Maladies Infectieuses ·Amaury Leruste, Jérôme Rambaud, Capucine Pïcard, Sophie Jarraud, A. Ferroni, C. Lawrence, Sylvain Renolleau	2016	5
2	Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients Bone Marrow Transplantation ·Betty K. Hamilton, Arjun Law, Lisa Rybicki, 赵浩然 ZHAO Hao-ran, Jane Dabney, Robert M. Dean, Hien K. Duong, Aaron T. Gerds, Rabi Hanna, Brian T. Hill, Deepa Jagadeesh, M Kalaycio, C. Lawrence, Linda McLellan, Brad Pohlman, Ronald Sobecks, Brian J. Bolwell, Navneet S. Majhail	2015	25
3	Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer Annals of Oncology ·J. A. Meyerhardt, Keith Stuart, Christiane Fuchs, Andrew X. Zhu, C. Suárez‐Plascencia, Pankaj Bhargava, Lawrence S. Blaszkowsky, Peter C. Enzinger, R. Mayer, Kurniati Rahmadani, C. Lawrence, D. P. Ryan	2007	63
4	A phase II study of pemetrexed in patients (pts) with advanced neuroendocrine tumors (NETs) Journal of Clinical Oncology ·Pankaj Bhargava, C. Suárez‐Plascencia, Andrew X. Zhu, Jeffrey W. Clark, Michele Vincitore, Kurniati Rahmadani, Eileen Regan, C. Lawrence, Matthew H. Kulke	2007	2
5	Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer Journal of Clinical Oncology ·Peter C. Enzinger, Torunn I. Yock, W. Warren Suh, P. Fidias, Harvey J. Mamon, Nayeon Choi, Paul-Laurent Assoun, C. Lawrence, Thomas J. Lynch, Charles S. Fuchs	2006	22
6	Hemoglobin C in Transgenic Mice: Effect of HbC Expression from Founders to Full Mouse Globin Knockouts Blood Cells Molecules and Diseases ·M E Fabry, José R. Romero, Sandra M. Suzuka, J. G. Gilman, Mirela Mosella, Daniela Viana Farias, S M Factor, Eric E. Bouhassira, C. Lawrence, R L Nagel	2000	10
7	Differential sensitivity of stilbenedisulfonates in their reaction with band 3 HT (Pro-868-->Leu). Proceedings of the National Academy of Sciences ·James M. Salhany, Lawrence M. Schopfer, Marguerite M.B. Kay, MAJ John S. Mason, C. Lawrence	1995	17
8	Rate of activation and deactivation of K?Cl cotransport by changes in cell volume in hemoglobin SS, CC and AA red cells The Journal of Membrane Biology ·Mitzy Canessa, José R. Romero, C. Lawrence, R L Nagel, M E Fabry	1994	28
9	Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868→Leu in the membrane domain of band 3 Biochemical Journal ·Lesley J. Bruce, Marguerite M.B. Kay, C. Lawrence, M J A Tanner	1993	50
10	Elliptocytosis associated with an abnormal α glycophorin Annals of Hematology ·YiQing Lü, Luanna Yukari Kubota Tavares, CH Huang, Olga O. Blumenfeld, Robert S. Schwartz, C. Lawrence, R L Nagel	1992	4
11	Evaluation of the Criteria for Diagnosis of Chronic Tension-Type Headache Cephalalgia ·Seymour Solomon, Bella Richard, C. Lawrence	1991	1
12	Etude de la couverture vaccinale antitétanique des blessés: Intérêt du Vacci-test® Médecine et Maladies Infectieuses ·Yan-Po Lin, Jiann‐Chyuan Wang, C. Lawrence, L. Grossi, W. Grimm, F Fraisse, Ryan Cranney, M. Cepek	1991	5
13	The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology Blood ·C. Lawrence, ME Fabry, RL Nagel	1991	46
14	The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology Blood ·C. Lawrence, ME Fabry, RL Nagel	1991	1
15	Membrane protein band 3 alteration associated with neurologic disease and tissue-reactive antibodies. PubMed ·Marguerite M.B. Kay, Joshua Goodman, Steven R. Goodman, C. Lawrence	1990	16
16	Radiographic abnormalities in coagulation factor VII deficiency. PubMed ·Jessica Sarah Jacoby, Sella Jamatul Kirana, C. Lawrence, Beverly Thornhill	1987	2
17	Spurious red-cell values with the Coulter Counter. PubMed ·C. Lawrence, 王益坚	1983	2
18	A noninvasive comparison of left ventricular performance in sickle cell anemia and chronic aortic regurgitation Clinical Cardiology ·Howard J. Willens, C. Lawrence, William H. Frishman, Joel A. Strom	1983	12

About C. Lawrence

C. Lawrence is a scholar working on Hematology, Genetics, Endocrinology, Physiology and Critical Care and Intensive Care Medicine, having authored 18 papers that have together received 311 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (7 papers), Hemoglobinopathies and Related Disorders (5 papers), Blood groups and transfusion (4 papers), Hemoglobin structure and function (3 papers), Neonatal Health and Biochemistry (2 papers), Gastric Cancer Management and Outcomes (2 papers), Blood properties and coagulation (1 paper) and Diphtheria, Corynebacterium, and Tetanus (1 paper). The work is most often cited by research in Hematology (85 citations), Genetics (77 citations), Physiology (127 citations), Oncology (87 citations) and Pediatrics, Perinatology and Child Health (53 citations). C. Lawrence has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Marguerite M.B. Kay, RL Nagel, ME Fabry, Lesley J. Bruce, M J A Tanner, José R. Romero, M E Fabry, Peter C. Enzinger, R L Nagel and Mitzy Canessa. Their work appears in journals such as Journal of Clinical Oncology, Blood, The Journal of Membrane Biology, Bone Marrow Transplantation and Cephalalgia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact